Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Queensland Health
Argus Health

Generated: March 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 076732

« Back to Dashboard

NDA 076732 describes METOLAZONE, which is a drug marketed by Mylan, Roxane, Sandoz, Teva, and Watson Labs, and is included in eight NDAs. It is available from eight suppliers. Additional details are available on the METOLAZONE profile page.

The generic ingredient in METOLAZONE is metolazone. There are nine drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the metolazone profile page.
Summary for 076732
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 076732
Physiological EffectIncreased Diuresis
Medical Subject Heading (MeSH) Categories for 076732
Suppliers and Packaging for NDA: 076732
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
METOLAZONE metolazone TABLET;ORAL 076732 ANDA Eon Labs, Inc. 0185-5050 N 0185-5050-01
METOLAZONE metolazone TABLET;ORAL 076732 ANDA Eon Labs, Inc. 0185-5050 N 0185-5050-10

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength2.5MG
Approval Date:Dec 19, 2003TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Daiichi Sankyo
US Department of Justice
Johnson and Johnson
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.